Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UKW-Inf-001 intermittent high-dose caspofungin prophylaxis PK/safety/efficacy trial
2009-015159-26Phase 2Active
- Sponsor
- University Hospital Würzburg
- Start
- Nov 2010
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caspofungin in invasive mycoses, aspergillosis, candidiasis, sponsored by University Hospital Würzburg. Started Nov 2010; status: active.
02
Drugs
caspofungin
03
Conditions
invasive mycosesaspergillosiscandidiasis
Beyond the preview
Go deeper on 2009-015159-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015159-26.